The Economic Impact on Australian Patients with Neuroendocrine Tumours

`Little is known about the economic burden to patients and families with neuroendocrine tumours (NETs) for medical out-of-pocket expenses and employment decisions. This study was preformed to determine the extent and factors influencing the financial consequences of living with NETs and their effect on quality of life’.

We are so grateful to the more then 200 Australian NET patients who participated in the study, with the results presented in poster form at this years annual European Neuroendocrine Tumour Society (ENETs) meeting. 

The study looked at a variety of costs and “highlighted the dual problem of cumulative out-of-pocket costs and early unanticipated retirement from the workforce.”

We will be using this information and looking at more prospective data as advocate to reduce costs for our patients. Well done to the authors including; Louise Gordan, Thomas Elliott, Kate Wakelin, Simone Leyden, John Leyden, Michael Michael, Nick Pavlakis, Jan Mumford, Eva Seglaov and David Wyld.

To read the article in full please click below on the paper.

Click Below to Read On

Share this post

Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print

Subscribe to our eNews

Stay up to date on news and events, clinical trials and new research on neuroendocrine cancers.

Recent posts

Related Posts


During May, Patient Voice Initiative are  running free webinars for patients, the topics are: Friday 14 May – Clinical trials and the patient voice How

Back to the Drive-In Fundraiser

A huge thank you to everyone from Kingpin Events and Village Cinemas for a fun and successful fundraiser on Saturday. The gates opened at 2:00pm

BNI A Team Golf Day in Adelaide

Last Friday, March 26 we were very grateful to be the chosen charity partner for BNI A Team Adelaide’s annual Golf Day. Along with Volunteers Jessica,